Nico Gagelmann/LinkedIn
Aug 22, 2026, 14:41
Nico Gagelmann: What is the Future for Patients with Myeloproliferative Neoplasms?
Nico Gagelmann, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“What is the future for patients with myeloproliferative neoplasms?
A snapshot from the episode of MYTHS & FACTS on Hematology and Cell Therapy with Claire Harrison.
Watch or listen to the full episode with lots more nuanced and deep insights on Youtube and on Spotify.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination
-
Aug 22, 2026, 15:13Arthur Allen: Empowering Clinicians to Act
-
Aug 22, 2026, 15:11Bassem M. Mohammed: Factor VIII Structure Analysis Makes the Cover of the Journal of Thrombosis and Haemostasis
-
Aug 22, 2026, 15:03Ahmed Reda: Your Red Blood Cell Can Tell a Story – Not All Anemia Looks the Same
-
Aug 22, 2026, 14:50Marco Meloni: Clinical Management of the Diabetic Foot Attack
-
Aug 22, 2026, 14:36Arun V J: Leadership Is a Practice, Not a Position – TRAM Masterclass with Judith Chapman
-
Aug 22, 2026, 13:38Jerome Hadjadj: A New Approach to Refractory Immune Thrombocytopenia
-
Aug 22, 2026, 13:25Christopher Robinson: Hematologic Response to Iron Therapy and Stillbirth Risk
-
Aug 22, 2026, 13:24Philippa Hill: Blood Clot Awareness – Recognize the Signs, Prevent the Risk